Body Part, Organ, or Organ Component – Page 4

Mitigating Risks in mRNA Manufacturing: Strategies for Smooth Transition from Preclinical to Clinical Stages

8 months ago talkbio0Tagged analytical method, Automation, bony process, clinical transition, Control Groups, Materials, Preclinical, Quality, regulatory, Risk Management, RNA, Messenger

mRNA manufacturing, risk management, preclinical to clinical transition, quality control, regulatory compliance, raw material selection, process automation, analytical methods.

Wave Life Sciences Sees Historic Stock Surge Following Breakthrough in RNA Editing Therapy

8 months ago talkbio0Tagged Clinical Trials, Hereditary Diseases, liver complications, Lung, RNA Editing, surge, Wave Life Sciences, WVE-006

Wave Life Sciences, RNA editing, genetic condition, lung and liver complications, WVE-006, biotech, stock surge, clinical trial data

European Medicines Agency Investigates Potential Link Between Hair Loss Drugs and Suicidal Thoughts

8 months ago talkbio0Tagged Agencies, European (ethnic group), Feeling suicidal (finding), finasteride, Hair, Multiple Acyl Coenzyme A Dehydrogenase Deficiency, psychiatric side effects

EMA, hair loss drugs, finasteride, dutasteride, suicidal thoughts, psychiatric side effects, European Medicines Agency

Aligos Therapeutics’ HERALD Study Shows Promising MASH Treatment Results, Yet Fails to Impress Investors

9 months ago talkbio0Tagged ALG-055009, Aligos, Clinical Research, HERALD, investor, Liver, MASH, phase 2a

Aligos Therapeutics, HERALD study, MASH treatment, ALG-055009, liver fat reduction, Phase 2a results, investor reaction.

AOA’s ‘Eye Deserve More’ Campaign Highlights the Unmatched Capabilities of the Human Eye

9 months ago talkbio0Tagged Americas Ethnicity, Blindness, Comprehensive Eye Care, Digital Eye Strain, Eye, Eye Deserve, Homo sapiens, Optometric Association, Optometry, The Eye

American Optometric Association, Eye Deserve More, The Eye, Human Eye, Eye Health, Comprehensive Eye Care, Digital Eye Strain, Vision Loss, Optometry

ImmunityBio Trims Workforce Despite Recent FDA Approval for Anktiva

9 months ago talkbio0Tagged Anktiva, Approved, Cancer Therapeutic Procedure, Financial Stress, ImmunityBio, United States Food and Drug Administration, Urinary Bladder

ImmunityBio, Anktiva, FDA approval, layoffs, financial challenges, bladder cancer treatment

Novartis and Versant Ventures Launch Borealis Biosciences to Develop RNA Medicines for Kidney Diseases

10 months ago talkbio0Tagged Biosciences, Biotechnology, Borealis, Kidney, Kidney Diseases, Novartis, RNA, RNA medicines, startup, Ventures, Versant, xRNA

Borealis Biosciences, Novartis, Versant Ventures, RNA medicines, kidney diseases, xRNA technology, biotechnology, startup, kidney research, RNA therapeutics.